CA Patent

CA1323568C — Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride

Assigned to Pacira Pharmaceuticals Inc · Expires 1993-10-26 · 33y expired

What this patent protects

Multivesicular Liposomes Having a Biologically Active Substance Encapsulated Therein In the Presence of a Hydrochloride Abstract of the Disclosure Disclosed are large multivesicular liposomes containing biologically active substances, the multivesicular liposomes having defined s…

USPTO Abstract

Multivesicular Liposomes Having a Biologically Active Substance Encapsulated Therein In the Presence of a Hydrochloride Abstract of the Disclosure Disclosed are large multivesicular liposomes containing biologically active substances, the multivesicular liposomes having defined size distribution, adjustible average size, adjustible internal chamber size and number, and having substantially higher encapsulation efficiency and substantially slower leakage rate of the biologically active substance than in the previous art. The process comprises dissolving a lipid component in volatile organic solvents, adding an immiscible aqueous component containing a hydrochloride and one or more biologically active substances to be encapsulated, making a water-in-oil emulsion from the two components, immersing the emulsion into a second aqueous component, dividing the emulsion into small solvent spherules which contain even smaller aqueous chambers, and then evaporating the solvents to give an aqueous suspension of multivesicular liposomes encapsulating biologically active substances.

Drugs covered by this patent

Patent Metadata

Patent number
CA1323568C
Jurisdiction
CA
Classification
Expires
1993-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Pacira Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.